Cargando…
Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score
Previous clinic models for patients with hepatocellular carcinoma (HCC) receiving transarterial chemoembolization (TACE) mainly focused on the overall survival, whereas a simple-to-use tool for predicting the response to the first TACE and the management of risk classification before TACE are lackin...
Autores principales: | Zhong, Jia-Wei, Nie, Dan-Dan, Huang, Ji-Lan, Luo, Rong-Guang, Cheng, Qing-He, Du, Qiao-Ting, Guo, Gui-Hai, Bai, Liang-Liang, Guo, Xue-Yun, Chen, Yan, Chen, Si-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581972/ https://www.ncbi.nlm.nih.gov/pubmed/37847433 http://dx.doi.org/10.1007/s12672-023-00803-2 |
Ejemplares similares
-
Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas
por: Zheng, Lin, et al.
Publicado: (2018) -
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023) -
Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study
por: Zhong, Chong, et al.
Publicado: (2018) -
Radiofrequency ablation combined with transarterial chemoembolization in treatment of hepatocellular carcinoma adjacent to the second hepatic hilus
por: Chen, Meng-Li, et al.
Publicado: (2021) -
Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
por: Guo, Jian-Hai, et al.
Publicado: (2020)